Celecoxib inhibits growth of tumors in a syngeneic rat liver metastases model for colorectal cancer

Article English OPEN
de Heer, Pieter; Sandel, Maro H.; Guertens, Gunther; de Boeck, Gert; Koudijs, Margaretha M.; Nagelkerke, J. Fred; Junggeburt, Jan M. C.; de Bruijn, Ernst A.; van de Velde, Cornelis J. H.; Kuppen, Peter J. K.;
(2008)
  • Publisher: Springer-Verlag
  • Journal: Cancer chemotherapy and pharmacology, volume 62, issue 5, pages 811-819 (issn: 0344-5704, eissn: 1432-0843)
  • Publisher copyright policies & self-archiving
  • Identifiers: pmc: PMC2516537, doi: 10.1007/S00280-007-0668-4
  • Subject: Toxicology | Original Article | Immune response | Celecoxib | Pharmacology | Cyclooxygenase-2 | Prostaglandins | Pharmacology (medical) | Cancer Research | Oncology | CC531 rat colon tumor liver metastases model
    mesheuropmc: musculoskeletal diseases

Abstract: Introduction Nonsteroidal anti-inflammatory drugs (NSAIDs) have been shown to reduce the risk of colorectal cancer in cyclooxygenase-2 (COX-2) overexpressing colorectal cancers. The present study was designed to evaluate the inhibitory effects of the COX-2 inh... View more
  • References (49)
    49 references, page 1 of 5

    1. Labianca R, Beretta G, Gatta G, de Braud F, Wils J (2004) Colon cancer. Crit Rev Oncol Hematol 51:145-170

    2. Thun MJ, Namboodiri MM, Heath CW Jr (1991) Aspirin use and reduced risk of fatal colon cancer. N Engl J Med 325:1593-1596

    3. Chan AT, Ogino S, Fuchs CS (2007) Aspirin and the risk of colorectal cancer in relation to the expression of COX-2. N Engl J Med 356:2131-2142

    4. Waskewich C, Blumenthal RD, Li H, Stein R, Goldenberg DM, Burton J (2002) Celecoxib exhibits the greatest potency amongst cyclooxygenase (COX) inhibitors for growth inhibition of COX-2-negative hematopoietic and epithelial cell lines. Cancer Res 62:2029-2033

    5. Steinbach G, Lynch PM, Phillips RK, Wallace MH, Hawk E, Gordon GB, Wakabayashi N, Saunders B, Shen Y, Fujimura T, Su LK, Levin B (2000) The eVect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med 342:1946- 1952

    6. Reddy BS, Hirose Y, Lubet R, Steele V, KelloV G, Paulson S, Seibert K, Rao CV (2000) Chemoprevention of colon cancer by speciWc cyclooxygenase-2 inhibitor, celecoxib, administered during diVerent stages of carcinogenesis. Cancer Res 60:293-297

    7. Sheng H, Shao J, Kirkland SC, Isakson P, CoVey RJ, Morrow J, Beauchamp RD, Dubois RN (1997) Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. J Clin Invest 99:2254-2259

    8. Dubois RN, Abramson SB, CroVord L, Gupta RA, Simon LS, Van De Putte LB, Lipsky PE (1998) Cyclooxygenase in biology and disease. FASEB J 12:1063-1073

    9. DuBois RN (1999) COX-2 in large bowel cancer: a one-sided story. Gut 45:636-637

    10. Dannenberg AJ, Altorki NK, Boyle JO, Dang C, Howe LR, Weksler BB, Subbaramaiah K (2001) Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer. Lancet Oncol 2:544-551

  • Related Organizations (7)
  • Metrics
Share - Bookmark